The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1236
ISSUE1236
June 5, 2006
Lubiprostone (Amitiza) for Chronic Constipation
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Lubiprostone (Amitiza) for Chronic Constipation
June 5, 2006 (Issue: 1236)
The FDA has approved lubiprostone (Amitiza - Sucampo/Takeda), a chloride channel activator, for treatment of chronic idiopathic constipation in adults. The only other prescription drug approved by the FDA for this indication (in 2004 for adults...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.